Document Detail


Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma.
MedLine Citation:
PMID:  20632449     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To evaluate the efficacy of transcatheter arterial chemoembolization (TACE) using a suspension of a fine-powder formulation of cisplatin (DDPH) for hepatocellular carcinoma (HCC).
METHODS: The study population was comprised of 164 patients who were treated by TACE alone. Of these patients, 76 underwent TACE using a suspension of DDPH in lipiodol (LPD) (DDPH group), and the remaining 88 underwent TACE with an emulsion of doxorubicin (ADM) with LPD (ADM group). We compared the DDPH group with the ADM group in terms of the objective early response rate, progression free survival (PFS) and overall survival (OS).
RESULTS: The objective early response rate in the DDPH group was significantly higher than that in the ADM group (54% vs 24%, P < 0.001). The PFS rate in the DDPH group was also significantly higher than that in the ADM group (P < 0.001). Moreover, the OS in the DDPH group was significantly longer than that in the ADM group (P = 0.002). Although the incidence rate of nausea or vomiting in the DDPH group was higher than that in the ADM group, the ADM group showed a higher incidence rate of the adverse events of hepatic arterial damage and leucopenia. No other serious complications were observed in either group.
CONCLUSION: We conclude that TACE using a suspension of DDPH in LPD could be a useful treatment for HCC.
Authors:
Kazuhiro Kasai; Akira Ushio; Kei Sawara; Yasuhiro Miyamoto; Yukiho Kasai; Kanta Oikawa; Hidekatsu Kuroda; Yasuhiro Takikawa; Kazuyuki Suzuki
Related Documents :
21388489 - (90) yttrium-hydroxyapatite: a new therapeutic option for radioactive synovectomy in ha...
21123089 - Objective quantification of seizure frequency and treatment success via long-term outpa...
15545559 - Comparison of a new fibrin sealant with standard topical hemostatic agents.
19715869 - Prophylactic therapy with valgancyclovir in high-risk (cytomegalovirus d+/r-) liver tra...
14599939 - Pre-ligation of afflicted hepatic inflow and outflow blood vessels of lesioned liver lo...
20333789 - Wilson disease: histopathological correlations with treatment on follow-up liver biopsies.
11493719 - Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis.
831009 - Heart valve replacement with the ionescu-shiley pericardial xenograft.
25289659 - Thyroid nodule morphology affects the efficacy of ultrasound-guided interstitial laser ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  World journal of gastroenterology : WJG     Volume:  16     ISSN:  2219-2840     ISO Abbreviation:  World J. Gastroenterol.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-15     Completed Date:  2010-10-18     Revised Date:  2014-05-20    
Medline Journal Info:
Nlm Unique ID:  100883448     Medline TA:  World J Gastroenterol     Country:  China    
Other Details:
Languages:  eng     Pagination:  3437-44     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Antineoplastic Agents* / administration & dosage,  therapeutic use
Carcinoma, Hepatocellular / drug therapy*
Chemistry, Pharmaceutical
Chemoembolization, Therapeutic
Cisplatin* / administration & dosage,  therapeutic use
Disease-Free Survival
Dosage Forms
Female
Humans
Liver Neoplasms / drug therapy*
Male
Middle Aged
Powders
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Dosage Forms; 0/Powders; Q20Q21Q62J/Cisplatin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk.
Next Document:  Association of genetic polymorphisms of aldehyde dehydrogenase-2 with esophageal squamous cell dyspl...